To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:
- • State issued document with your organization's Federal Tax ID Number
- • State issued document with your organization's Resale Tax ID Number
- • City or County issued Business License
- • State Department of Health Services License
- • Any other ID issued by the State that includes the business name & address
* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.
Specifications
- Description:BL21(DE3)pLysS Competent Cells, >10(6)cfu/ug, 1ml
- Size:1ml
- Storage Conditions:Store at –70°C
- Cat. No.:PAL1191
- Supplier no.:L1191
Specifications
About this item
BL21(DE3)pLysS Competent Cells allow high-efficiency protein expression of any gene that is under the control of a T7 promoter and has a ribosome binding site.
- High-Efficiency Protein Expression from Gene with T7 Promoter and Ribosome Binding Site
- Inducible protein expression from gene with T7 RNA polymerase controlled by lac UV5 promoter
- Increased stability of expressed protein from deficiency in proteases lon and OmpT
- Lower background expression of target genes with pLysS plasmid
BL21(DE3)pLysS Competent Cells allow high-efficiency protein expression of any gene that is under the control of a T7 promoter and has a ribosome binding site. BL21(DE3)pLysS is lysogenic for lambda-DE3, which contains the T7 bacteriophage gene I, encoding T7 RNA polymerase under the control of the lac UV5 promoter. BL21(DE3)pLysS also contains a plasmid, pLysS, which carries the gene encoding T7 lysozyme. T7 lysozyme lowers the background expression level of target genes under the control of the T7 promoter but does not interfere with the level of expression achieved following induction by IPTG. For researchers doing more than one transformation, competent cells are available in standard format (200ul aliquots). For added convenience, single-use competent cells (50ul aliquots) also are offered. Genotype: F-, ompT, hsdS(B) (r(B)-, m(B)-), dcm, gal, lambda(DE3), pLysS, Cm(r).
For researchers doing more than one transformation, competent cells are available in standard format (200 µL aliquots). For added convenience, single-use competent cells (50 µL aliquots) also are offered.
BL21(DE3)pLysS also contains a plasmid, pLysS, which carries the gene encoding T7 lysozyme. T7 lysozyme lowers the background expression level of target genes under the control of the T7 promoter but does not interfere with the level of expression achieved following induction by IPTG.